RELX | ||
---|---|---|
OUTLOOK RATING 1..100 | 62 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 90 Overvalued | |
PROFIT vs RISK RATING 1..100 | 7 | |
SMR RATING 1..100 | 30 | |
PRICE GROWTH RATING 1..100 | 63 | |
P/E GROWTH RATING 1..100 | 56 | |
SEASONALITY SCORE 1..100 | 55 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
GINX | RELX | |
---|---|---|
RSI ODDS (%) | 2 days ago78% | 2 days ago76% |
Stochastic ODDS (%) | 2 days ago68% | 2 days ago73% |
Momentum ODDS (%) | 2 days ago80% | 2 days ago45% |
MACD ODDS (%) | 2 days ago87% | 2 days ago39% |
TrendWeek ODDS (%) | 2 days ago87% | 2 days ago39% |
TrendMonth ODDS (%) | 2 days ago82% | 2 days ago41% |
Advances ODDS (%) | 4 days ago87% | 24 days ago55% |
Declines ODDS (%) | 16 days ago60% | 3 days ago42% |
BollingerBands ODDS (%) | 2 days ago75% | 2 days ago76% |
Aroon ODDS (%) | 2 days ago90% | 2 days ago43% |
A.I.dvisor tells us that GINX and GSK have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GINX and GSK's prices will move in lockstep.
Ticker / NAME | Correlation To GINX | 1D Price Change % | ||
---|---|---|---|---|
GINX | 100% | +0.47% | ||
GSK - GINX | 21% Poorly correlated | +1.44% | ||
NVS - GINX | 21% Poorly correlated | +1.74% | ||
KMB - GINX | 20% Poorly correlated | -0.34% | ||
RELX - GINX | 20% Poorly correlated | +0.57% | ||
KO - GINX | 19% Poorly correlated | +0.53% | ||
More |